Loading…

Phillips-Medisize, a Molex company, announced an initial investment to expand the Molex Little Rock facility to include a FDA-registered manufacturing Center of Excellence for connected health and drug delivery devices. Production is scheduled to begin in Q2 2018.
“Phillips-Medisize has announced its initial investment to expand the capabilities of the 380,000-square-foot Molex Little Rock facility to include a FDA-registered manufacturing Center of Excellence for connected health and drug delivery devices.”mpo-mag.com
Summarized from public sources; check the original articles before acting on it.